iTonic Holdings (ITOC) Other Accumulated Expenses (2023)

iTonic Holdings (ITOC) reported Other Accumulated Expenses of $985043.0 for Q4 2023.

iTonic Holdings (ITOC) Other Accumulated Expenses (2023) Analysis & Trends

iTonic Holdings (ITOC) has 1 years of Other Accumulated Expenses data on file, last reported at $985043.0 in Q4 2023.

For the quarter ending Q4 2023, Other Accumulated Expenses changed N/A year-over-year to $985043.0; the trailing twelve-month figure through Dec 2023 stood at $985043.0 (changed N/A YoY), and the FY2023 full-year result was $985043.0, changed N/A from the prior year.
Other Accumulated Expenses held at $985043.0 in Q4 2023.
In the past five years, Other Accumulated Expenses ranged from a high of $985043.0 in Q4 2023 to a low of $985043.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.55 Bn	176.26 Bn	6.27 Bn
2	Stryker	128.64 Bn	125.76 Bn	3.81 Bn
3	Medtronic	108.92 Bn	99.70 Bn	6.41 Bn
4	Boston Scientific	68.50 Bn	67.05 Bn	3.61 Bn
5	Edwards Lifesciences	47.84 Bn	44.17 Bn	1.29 Bn
6	GE HealthCare Technologies	28.25 Bn	25.96 Bn	1.98 Bn
7	Dexcom	28.23 Bn	27.11 Bn	750.30 Mn
8	Smith & Nephew	26.93 Bn	26.35 Bn	-
9	Koninklijke Philips	25.43 Bn	22.30 Bn	2.07 Bn
10	iTonic Holdings	4.33 Mn	1.40 Mn	-

Download Data

Date	Value
Dec 31, 2023	985,043.00